Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 521

1.

ST2/IL-33 signaling in cardiac fibrosis.

Vianello E, Dozio E, Tacchini L, Frati L, Corsi Romanelli MM.

Int J Biochem Cell Biol. 2019 Nov;116:105619. doi: 10.1016/j.biocel.2019.105619. Epub 2019 Sep 24.

PMID:
31561019
2.

Aspirin-Dependent Effects on Purinergic P2Y1 Receptor Expression.

Massimi I, Alemanno L, Guarino ML, Guerriero R, Mancone M, Ceccacci A, Frati L, Angiolillo DJ, Pulcinelli FM.

Thromb Haemost. 2019 May;119(5):726-734. doi: 10.1055/s-0039-1678707. Epub 2019 Feb 13.

PMID:
30759486
3.

Non-steroidal anti-inflammatory drugs increase MRP4 expression in an endometriotic epithelial cell line in a PPARa dependent manner.

Massimi I, Pulcinelli FM, Piscitelli VP, Alemanno L, Maltese T, Guarino ML, Marci R, Canny GO, Frati L, Mallozzi M, Frega A, Caserta D.

Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8487-8496. doi: 10.26355/eurrev_201812_16549.

4.

Nanoparticle-biomolecular corona: A new approach for the early detection of non-small-cell lung cancer.

Di Domenico M, Pozzi D, Palchetti S, Digiacomo L, Iorio R, Astarita C, Fiorelli A, Pierdiluca M, Santini M, Barbarino M, Giordano A, Di Carlo A, Frati L, Mahmoudi M, Caracciolo G.

J Cell Physiol. 2019 Jun;234(6):9378-9386. doi: 10.1002/jcp.27622. Epub 2018 Dec 5.

PMID:
30520022
5.

Effects of aloe emodin on U87MG glioblastoma cell growth: In vitro and in vivo study.

Arcella A, Oliva MA, Staffieri S, Sanchez M, Madonna M, Riozzi B, Esposito V, Giangaspero F, Frati L.

Environ Toxicol. 2018 Nov;33(11):1160-1167. doi: 10.1002/tox.22622. Epub 2018 Sep 15.

PMID:
30218594
6.

MiR-21 role in aspirin-dependent PPARα and multidrug resistance protein 4 upregulation.

Massimi I, Alemanno L, Guarino ML, Guerriero R, Frati L, Biasucci L, Pulcinelli FM.

Res Pract Thromb Haemost. 2018 May 17;2(3):596-606. doi: 10.1002/rth2.12104. eCollection 2018 Jul.

7.

Brain Targeting by Liposome-Biomolecular Corona Boosts Anticancer Efficacy of Temozolomide in Glioblastoma Cells.

Arcella A, Palchetti S, Digiacomo L, Pozzi D, Capriotti AL, Frati L, Oliva MA, Tsaouli G, Rota R, Screpanti I, Mahmoudi M, Caracciolo G.

ACS Chem Neurosci. 2018 Dec 19;9(12):3166-3174. doi: 10.1021/acschemneuro.8b00339. Epub 2018 Jul 31.

PMID:
30015470
8.

Interventions to Reduce Neurological Symptoms in Patients with GBM Receiving Radiotherapy: From Theory to Clinical Practice.

Palombi L, Marchetti P, Salvati M, Osti MF, Frati L, Frati A.

Anticancer Res. 2018 Apr;38(4):2423-2427.

PMID:
29599372
9.

Lichen planus: molecular pathway and clinical implications in oral disorders.

Boccellino M, Di Stasio D, Romano A, Petruzzi M, Lucchese A, Serpico R, Frati L, Di Domenico M.

J Biol Regul Homeost Agents. 2018 Jan-Feb;32(2 Suppl. 1):135-138. Review.

PMID:
29460532
10.

Impact of Multidrug Resistance Protein-4 Inhibitors on Modulating Platelet Function and High on-Aspirin Treatment Platelet Reactivity.

Alemanno L, Massimi I, Klaus V, Guarino ML, Maltese T, Frati L, Angiolillo DJ, Pulcinelli FM.

Thromb Haemost. 2018 Mar;118(3):490-501. doi: 10.1055/s-0038-1629920. Epub 2018 Feb 15.

PMID:
29448294
11.

Scarce evidence of ozone effect on recent health and productivity of alpine forests-a case study in Trentino, N. Italy.

Ferretti M, Bacaro G, Brunialti G, Confalonieri M, Cristofolini F, Cristofori A, Frati L, Finco A, Gerosa G, Maccherini S, Gottardini E.

Environ Sci Pollut Res Int. 2018 Mar;25(9):8217-8232. doi: 10.1007/s11356-018-1195-z. Epub 2018 Jan 20.

PMID:
29352394
12.

Implementing the Risk of Ovarian Malignancy Algorithm Adding Obesity as a Predictive Factor.

Anastasi E, Capoccia D, Granato T, Silecchia G, Rizzello M, Porpora MG, Frati L, Angeloni A, Leonetti F.

Anticancer Res. 2016 Dec;36(12):6425-6429.

PMID:
27919964
13.

Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment.

Massimi I, Lotti LV, Temperilli F, Mancone M, Sardella G, Calcagno S, Turriziani O, Frati L, Pulcinelli FM.

Thromb Haemost. 2016 Nov 30;116(6):1100-1110. Epub 2016 Sep 29.

PMID:
27683757
14.

Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients.

Viggiani V, Palombi S, Gennarini G, D'Ettorre G, De Vito C, Angeloni A, Frati L, Anastasi E.

Scand J Gastroenterol. 2016 Oct;51(10):1257-62. doi: 10.1080/00365521.2016.1183705. Epub 2016 May 26.

PMID:
27227515
15.

Terapeutic Potential of Microencapsulated Sertoli Cells in Huntington Disease.

Luca G, Bellezza I, Arato I, Di Pardo A, Mancuso F, Calvitti M, Falabella G, Bartoli S, Maglione V, Amico E, Favellato M, Basta G, Bodo M, Minelli A, Calafiore R, Frati L, Squitieri F.

CNS Neurosci Ther. 2016 Aug;22(8):686-90. doi: 10.1111/cns.12569. Epub 2016 May 26.

16.

Nonsteroidal anti-inflammatory drugs in-vitro and in-vivo treatment and Multidrug Resistance Protein 4 expression in human platelets.

Temperilli F, Di Franco M, Massimi I, Guarino ML, Guzzo MP, Valesini G, Frati L, Pulcinelli FM.

Vascul Pharmacol. 2016 Jan;76:11-7. doi: 10.1016/j.vph.2015.06.016. Epub 2015 Jul 2.

PMID:
26141932
17.

Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model.

Squitieri F, Di Pardo A, Favellato M, Amico E, Maglione V, Frati L.

J Cell Mol Med. 2015 Nov;19(11):2540-8. doi: 10.1111/jcmm.12604. Epub 2015 Jun 22.

18.

Epstein-Barr virus infection induces miR-21 in terminally differentiated malignant B cells.

Anastasiadou E, Garg N, Bigi R, Yadav S, Campese AF, Lapenta C, Spada M, Cuomo L, Botta A, Belardelli F, Frati L, Ferretti E, Faggioni A, Trivedi P.

Int J Cancer. 2015 Sep 15;137(6):1491-7. doi: 10.1002/ijc.29489. Epub 2015 Mar 4.

19.

Triple-negative breast cancer: new perspectives for targeted therapies.

Tomao F, Papa A, Zaccarelli E, Rossi L, Caruso D, Minozzi M, Vici P, Frati L, Tomao S.

Onco Targets Ther. 2015 Jan 16;8:177-93. doi: 10.2147/OTT.S67673. eCollection 2015. Review.

20.

Topical KGF treatment as a therapeutic strategy for vaginal atrophy in a model of ovariectomized mice.

Ceccarelli S, D'Amici S, Vescarelli E, Coluccio P, Matricardi P, di Gioia C, Benedetti Panici P, Romano F, Frati L, Angeloni A, Marchese C.

J Cell Mol Med. 2014 Sep;18(9):1895-907. doi: 10.1111/jcmm.12334. Epub 2014 Aug 1.

21.

Biomonitoring urban air pollution using transplanted lichens: element concentrations across seasons.

Malaspina P, Tixi S, Brunialti G, Frati L, Paoli L, Giordani P, Modenesi P, Loppi S.

Environ Sci Pollut Res Int. 2014 Nov;21(22):12836-42. doi: 10.1007/s11356-014-3222-z. Epub 2014 Jun 28.

PMID:
24969430
22.

Aspirin influences megakaryocytic gene expression leading to up-regulation of multidrug resistance protein-4 in human platelets.

Massimi I, Guerriero R, Lotti LV, Lulli V, Borgognone A, Romani F, Barillà F, Gaudio C, Gabbianelli M, Frati L, Pulcinelli FM.

Br J Clin Pharmacol. 2014 Dec;78(6):1343-53. doi: 10.1111/bcp.12432.

23.

May increased CA125 in borderline ovarian tumor be indicative of a poor prognosis? A case report.

Anastasi E, Porpora MG, Pecorella I, Bernardo S, Frati L, Benedetti Panici P, Manganaro L.

Tumour Biol. 2014 Jul;35(7):6969-71. doi: 10.1007/s13277-014-1898-9. Epub 2014 Apr 17.

PMID:
24740561
24.

Hepatitis C virus present in the sera of infected patients interferes with the autophagic process of monocytes impairing their in-vitro differentiation into dendritic cells.

Granato M, Lacconi V, Peddis M, Di Renzo L, Valia S, Rivanera D, Antonelli G, Frati L, Faggioni A, Cirone M.

Biochim Biophys Acta. 2014 Jul;1843(7):1348-55. doi: 10.1016/j.bbamcr.2014.04.003. Epub 2014 Apr 12.

25.

Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.

Veschi V, Petroni M, Bartolazzi A, Altavista P, Dominici C, Capalbo C, Boldrini R, Castellano A, McDowell HP, Pizer B, Frati L, Screpanti I, Gulino A, Giannini G.

Cell Death Dis. 2014 Mar 6;5:e1100. doi: 10.1038/cddis.2014.68.

26.

Pathogen-free, plasma-poor platelet lysate and expansion of human mesenchymal stem cells.

Iudicone P, Fioravanti D, Bonanno G, Miceli M, Lavorino C, Totta P, Frati L, Nuti M, Pierelli L.

J Transl Med. 2014 Jan 27;12:28. doi: 10.1186/1479-5876-12-28.

27.

Is CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer?

Anastasi E, Manganaro L, Granato T, Benedetti Panici P, Frati L, Porpora MG.

Dis Markers. 2013;35(5):331-5. doi: 10.1155/2013/984641. Epub 2013 Sep 22.

28.

JNK and macroautophagy activation by bortezomib has a pro-survival effect in primary effusion lymphoma cells.

Granato M, Santarelli R, Lotti LV, Di Renzo L, Gonnella R, Garufi A, Trivedi P, Frati L, D'Orazi G, Faggioni A, Cirone M.

PLoS One. 2013 Sep 26;8(9):e75965. doi: 10.1371/journal.pone.0075965. eCollection 2013.

29.

Serum HE4 levels combined with CE CT imaging improve the management of monitoring women affected by epithelial ovarian cancer.

Manganaro L, Michienzi S, Vinci V, Falzarano R, Saldari M, Granato T, Viggiani V, Frati L, Anastasi E.

Oncol Rep. 2013 Nov;30(5):2481-7. doi: 10.3892/or.2013.2682. Epub 2013 Aug 21.

PMID:
23970060
30.

HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma.

Granato M, Lacconi V, Peddis M, Lotti LV, Di Renzo L, Gonnella R, Santarelli R, Trivedi P, Frati L, D'Orazi G, Faggioni A, Cirone M.

Cell Death Dis. 2013 Jul 18;4:e730. doi: 10.1038/cddis.2013.263. Erratum in: Cell Death Dis. 2014;5:e2154. Renzo, L D [corrected to Di Renzo, L].

31.

The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer.

Anastasi E, Granato T, Falzarano R, Storelli P, Ticino A, Frati L, Panici PB, Porpora MG.

J Ovarian Res. 2013 Jul 1;6(1):44. doi: 10.1186/1757-2215-6-44.

32.

Evaluation of a CLEIA automated assay system for the detection of a panel of tumor markers.

Falzarano R, Viggiani V, Michienzi S, Longo F, Tudini S, Frati L, Anastasi E.

Tumour Biol. 2013 Oct;34(5):3093-100. doi: 10.1007/s13277-013-0877-x. Epub 2013 Jun 18.

PMID:
23775009
33.

Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff?

Gazzaniga P, Raimondi C, Gradilone A, Biondi Zoccai G, Nicolazzo C, Gandini O, Longo F, Tomao S, Lo Russo G, Seminara P, Vincenzi B, Chimenti I, Cristofanilli M, Frati L, Cortesi E.

J Cancer Res Clin Oncol. 2013 Aug;139(8):1411-6. doi: 10.1007/s00432-013-1450-0. Epub 2013 Jun 5.

PMID:
23736274
34.

TNFα modulates Fibroblast Growth Factor Receptor 2 gene expression through the pRB/E2F1 pathway: identification of a non-canonical E2F binding motif.

D'Amici S, Ceccarelli S, Vescarelli E, Romano F, Frati L, Marchese C, Angeloni A.

PLoS One. 2013 Apr 16;8(4):e61491. doi: 10.1371/journal.pone.0061491. Print 2013.

35.

Circulating tumor cells in high-risk nonmetastatic colorectal cancer.

Gazzaniga P, Gianni W, Raimondi C, Gradilone A, Lo Russo G, Longo F, Gandini O, Tomao S, Frati L.

Tumour Biol. 2013 Oct;34(5):2507-9. doi: 10.1007/s13277-013-0752-9. Epub 2013 Mar 29.

PMID:
23539436
36.

Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: analysis in primary cell cultures of human prostate carcinoma.

Silvestri I, Cattarino S, Aglianò A, Nicolazzo C, Scarpa S, Salciccia S, Frati L, Gentile V, Sciarra A.

J Inflamm (Lond). 2013 Mar 14;10:11. doi: 10.1186/1476-9255-10-11. eCollection 2013.

37.

Breast cancer risk after exposure to fertility drugs.

Lo Russo G, Spinelli GP, Tomao S, Rossi B, Frati L, Panici PB, Vici P, Codacci Pisanelli G, Tomao F.

Expert Rev Anticancer Ther. 2013 Feb;13(2):149-57. doi: 10.1586/era.12.181. Review.

PMID:
23406556
38.

Oxidative stress posttranslationally regulates the expression of Ha-Ras and Ki-Ras in cultured astrocytes.

Messina S, Frati L, Porcellini A.

Oxid Med Cell Longev. 2012;2012:792705. doi: 10.1155/2012/792705. Epub 2012 Oct 31.

39.

Activation of dendritic cells by tumor cell death.

Cirone M, Di Renzo L, Lotti LV, Conte V, Trivedi P, Santarelli R, Gonnella R, Frati L, Faggioni A.

Oncoimmunology. 2012 Oct 1;1(7):1218-1219.

40.

Galectin-3 impairment of MYCN-dependent apoptosis-sensitive phenotype is antagonized by nutlin-3 in neuroblastoma cells.

Veschi V, Petroni M, Cardinali B, Dominici C, Screpanti I, Frati L, Bartolazzi A, Gulino A, Giannini G.

PLoS One. 2012;7(11):e49139. doi: 10.1371/journal.pone.0049139. Epub 2012 Nov 9.

41.

CLEIA CA125 evidences: good analytical performance avoiding "Hook effect".

Falzarano R, Viggiani V, Michienzi S, Colaprisca B, Longo F, Frati L, Anastasi E.

Tumour Biol. 2013 Feb;34(1):387-93. doi: 10.1007/s13277-012-0561-6. Epub 2012 Nov 1.

PMID:
23111756
42.

Prognostic significance of tyrosinase expression in sentinel lymph node biopsy for ultra-thin, thin, and thick melanomas.

Gradilone A, Gazzaniga P, Ribuffo D, Bottoni U, Frati L, Aglian AM, Sorvillo V, Piperno A, Scuderi N, Cigna E.

Eur Rev Med Pharmacol Sci. 2012 Oct;16(10):1367-76.

43.

Chemotherapy and target therapy in the management of adult high- grade gliomas.

Spinelli GP, Miele E, Lo Russo G, Miscusi M, Codacci-Pisanelli G, Petrozza V, Papa A, Frati L, Della Rocca C, Gulino A, Tomao S.

Curr Cancer Drug Targets. 2012 Oct;12(8):1016-31. Review.

PMID:
22831277
44.

Circulating tumor cells in young and elderly patients with colorectal cancer: "lupus et agnus".

Gazzaniga P, Gianni W, Gradilone A, Raimondi C, Cortesi E, Frati L.

Aging Clin Exp Res. 2012 Dec;24(6):722-3. doi: 10.3275/8519. Epub 2012 Jul 24. No abstract available.

PMID:
22828412
45.

Syk-dependent regulation of Hrs phosphorylation and ubiquitination upon FcεRI engagement: impact on Hrs membrane/cytosol localization.

Gasparrini F, Molfetta R, Quatrini L, Frati L, Santoni A, Paolini R.

Eur J Immunol. 2012 Oct;42(10):2744-53. doi: 10.1002/eji.201142278. Epub 2012 Jul 25.

46.

Spatial scales of variation in lichens: implications for sampling design in biomonitoring surveys.

Giordani P, Brunialti G, Frati L, Incerti G, Ianesch L, Vallone E, Bacaro G, Maccherini S.

Environ Monit Assess. 2013 Feb;185(2):1567-76. doi: 10.1007/s10661-012-2651-8. Epub 2012 May 25.

PMID:
22628101
47.

Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2.

Rosato P, Anastasiadou E, Garg N, Lenze D, Boccellato F, Vincenti S, Severa M, Coccia EM, Bigi R, Cirone M, Ferretti E, Campese AF, Hummel M, Frati L, Presutti C, Faggioni A, Trivedi P.

Leukemia. 2012 Nov;26(11):2343-52. doi: 10.1038/leu.2012.108. Epub 2012 Apr 19.

48.

HHV-8 reduces dendritic cell migration through down-regulation of cell-surface CCR6 and CCR7 and cytoskeleton reorganization.

Cirone M, Conte V, Farina A, Valia S, Trivedi P, Granato M, Santarelli R, Frati L, Faggioni A.

Virol J. 2012 May 14;9:92. doi: 10.1186/1743-422X-9-92.

49.

Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation.

Napoletano C, Zizzari IG, Rughetti A, Rahimi H, Irimura T, Clausen H, Wandall HH, Belleudi F, Bellati F, Pierelli L, Frati L, Nuti M.

Eur J Immunol. 2012 Apr;42(4):936-45. doi: 10.1002/eji.201142086.

50.

Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer.

Granato T, Midulla C, Longo F, Colaprisca B, Frati L, Anastasi E.

Tumour Biol. 2012 Oct;33(5):1335-9. doi: 10.1007/s13277-012-0381-8. Epub 2012 Apr 13.

PMID:
22528938

Supplemental Content

Support Center